Ocular Therapeutix, Inc. (OCUL)

Ocular Therapeutix Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	391.13	392.1	195.81	102.3	164.16	228.06
Cash & Short-Term Investments	391.13	392.1	195.81	102.3	164.16	228.06
Cash Growth	-14.91%	100.25%	91.41%	-37.68%	-28.02%	318.94%
Accounts Receivable	30.41	32.39	26.18	21.33	21.14	12.25
Other Receivables	0.32	0.18	-	-	-	-
Receivables	30.73	32.56	26.18	21.33	21.14	12.25
Inventory	3.04	3.04	2.31	1.97	1.25	1.2
Prepaid Expenses	8.47	13.28	7.79	4.03	4.75	3.39
Restricted Cash	-	-	0.15	-	-	-
Other Current Assets	-	-	-	-	-	1.26
Total Current Assets	433.38	440.99	232.24	129.63	191.3	246.16
Property, Plant & Equipment	16.34	15.33	18.21	17.9	11.82	13.94
Other Long-Term Assets	1.61	1.61	1.61	1.76	1.76	1.76
Total Assets	451.33	457.94	252.06	149.29	204.89	261.86
Accounts Payable	5.89	4.18	4.39	5.12	4.59	2.71
Accrued Expenses	34.42	35.12	28.67	24.1	20.12	14.31
Current Portion of Long-Term Debt	-	-	-	-	-	8.29
Current Portion of Leases	2.63	1.93	1.59	1.6	1.62	1.36
Current Unearned Revenue	-	0.13	0.26	0.58	-	-
Total Current Liabilities	42.93	41.35	34.9	31.4	26.34	26.66
Long-Term Debt	69.91	68.51	74.93	54.01	51.44	41.24
Long-Term Leases	4.41	5.35	6.88	8.68	5.92	7.55
Long-Term Unearned Revenue	14	14	14.14	13.39	13	12
Other Long-Term Liabilities	14.17	13.39	30.1	6.44	20.19	98.31
Total Liabilities	145.42	142.59	160.93	113.91	116.89	185.77
Common Stock	0.02	0.02	0.01	0.01	0.01	0.01
Additional Paid-In Capital	1,329	1,206	788.7	652.21	633.8	615.34
Retained Earnings	-1,023	-891.08	-697.58	-616.84	-545.8	-539.25
Shareholders' Equity	305.92	315.34	91.13	35.38	88	76.1
Total Liabilities & Equity	451.33	457.94	252.06	149.29	204.89	261.86
Total Debt	76.94	75.78	83.39	64.28	58.98	58.44
Net Cash (Debt)	314.2	316.32	112.42	38.02	105.18	169.62
Net Cash Growth	-18.35%	181.38%	195.70%	-63.86%	-37.99%	-
Net Cash Per Share	1.86	2.00	1.31	0.46	1.28	2.79
Filing Date Shares Outstanding	174	159.02	148.63	77.51	76.75	76.07
Total Common Shares Outstanding	172.93	157.75	114.96	77.2	76.73	76
Working Capital	390.44	399.63	197.34	98.23	164.96	219.5
Book Value Per Share	1.77	2.00	0.79	0.46	1.15	1.00
Tangible Book Value	305.92	315.34	91.13	35.38	88	76.1
Tangible Book Value Per Share	1.77	2.00	0.79	0.46	1.15	1.00
Machinery	-	18.05	16.78	13.75	12.28	11.47
Construction In Progress	-	0.12	0.28	4.07	0.58	0.12
Leasehold Improvements	-	14.53	14.7	9.07	9.07	9.07

Updated Aug 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q